Back

First 12-month follow-up of bioresorbable synthetic heart valves implanted in the aortic position in sheep

29 August 2022 (12:15 - 12:55)
Organised by:
Congress Presentation Part of: Tissue engineering and other models for cardiovascular disease Valvular Heart Disease ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Miss Annemijn Vis

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
Injectable carbon nanotube-functionalized hydrogel as a tool for cardiac tissue engineering
Assistant Professor B. Pena (Aurora, US)
Abstract Slides
Presentation thumbnail
The ex vivo on-ECMO amputated human limb model of atherosclerosis
Doctor A. Hartley (London, GB)
Abstract Slides
Presentation thumbnail
Pioglitazone-incorporated microspheres alleviates cardiac dysfunction through macrophage polarization in a rat myocardial infarction model
Doctor Y. Konegawa (Kyoto, JP)
Abstract Slides
Presentation thumbnail
Crosstalk between PKR1 and miR-124 is crucial for EMT regulation of tc21+epicardial mesothelial cells during cardiac development and repair process
Professor C. Nebigil (Strasbourg, FR)
Abstract Slides
Presentation thumbnail
Hyperglycaemia-induced degeneration of bioprosthetic valve tissue and the pivotal role of the extracellular matrix molecule biglycan
Doctor J. Selig (Duesseldorf, DE)
Abstract Slides

Access the full session

Session thumbnail
Tissue engineering and other models for cardiovascular disease

The Event

Event poster

ESC Congress 2022

29 August 2022 12:15 CET
You may be interested in
thumbnail
Congress Session
Acute heart failure and valvular heart disease
thumbnail
Congress Session
How to manage valvular heart disease in heart failure
thumbnail
Congress Session
Personalised approach to decompensated heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources